Great Lakes Division


Liver-Related Information

In Your Area

Clinical Trials

Find Great Lakes Division area Clinical Trials currently accepting new patients.


Alcoholic Hepatitis Clinical Trial

Rush University Medical Center, Chicago, IL


alcoholic hepatits

Learn more here.
Contact: Dr. Nikunj Shah (312)942-8910


Alcohol-Induced Liver Decompensation Treatment Study

Rush University Medical Center, Chicago, IL

ELAD is an investigational human liver cell-based treatment designed to improve survival of subjects with liver failure by providing liver support continuously for up to five days. This study specifically focuses on individuals with alcohol-induced liver decompensation (AILD). Overall, 150 patients will be recruited for this study. At Rush University Medical Center, we expect to enroll 5 patients. The treatment will be assigned randomly. Learn more here.

Contact: Diana Giczewski (312)563-3919


Non-Alcoholic Steato-hepatitis (NASH) Drug Treatment Study

Rush University Medical Center, Chicago, IL The purpose of this study is to test whether a drug called emricasan (IDN-6556) can decrease the amount of scarring (fibrosis) in the liver caused by the presence of fat. This drug will be compared with placebo in patients with NASH. Nationwide and in Europe, 330 patients will be enrolled in this study. Rush University Medical Center expects to enroll 5 patients.

Contact: Diana Giczewski (312)563-3919


NAFLD/NASH Clinical Trial

Northwestern Memorial, Chicago, IL

Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic steatohepatitis (NASH) are the leading causes of chronic liver disease in the Western World. Unfortunately, there are currently no FDA approved treatments for NAFLD/NASH (including patients with cirrhosis), but new treatments are on the horizon! Northwestern University is actively enrolling patients with NAFLD and NASH in numerous clinical drug treatment trials (clinicaltrials.gov).

If you or your patients have a diagnosis of NAFLD/NASH please contact: Dr. Mary Rinella, the study coordinator Stasha Milosevic 312-694-0326, or Kim Sipich 312-694-1293 to obtain more information.


Liver Research and Clinical Trials

Northwestern Memorial, Chicago, IL

As a premier academic medical center, Northwestern Memorial and its collaborative partner Northwestern University Feinberg School of Medicine are committed to the advancement of healthcare through clinical innovation, medical education and scientific research.

Our physicians participate in a wide range of clinical trials to improve the treatment of patients with liver disease including, acute/chronic liver failure, auto-immune hepatitis, HCC, Hepatitis B, Hepatitis C, NASH, PBC, PSC. To find out if a research trial is being conducted that fits your needs, please call one of the following study coordinators to assist you:

Kim Sipich 312-694-1293, Jeanne Gottstein 312-694-0264, or Noreen Khan 312-694-1295.


Introduction to Clinical Trials

An American Liver Foundation Guide

The American Liver Foundation’s Introduction to Clinical Trials guide contains information on what a clinical trial is, who is involved, how the process works, potential risks and benefits, and much more.

For information on clinical trials in your area:
• Search the National Institutes of Health’s clinical trials website
• Talk to your healthcare provider about clinical trials that you may be eligible for
• Contact local medical institutions to learn about upcoming clinical trials

Page updated: May 30th, 2017

 

末末末末末末末末 Begin Code for Siteimprove Analytics 末末末末